BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4327165)

  • 1. [Immunochemical study of the enzymes of a toxic complex of Cl. perfringens].
    Ispolatovskaia MV; Klimacheva LV; Tokinova TN; Larina IA
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Apr; 48(4):89-93. PubMed ID: 4327165
    [No Abstract]   [Full Text] [Related]  

  • 2. [Structure and function of Cl. perfringens toxin].
    Ispolatovskaia MV
    Vestn Akad Med Nauk SSSR; 1973; 28(11):83-9. PubMed ID: 4132138
    [No Abstract]   [Full Text] [Related]  

  • 3. [A study of the enzymes of the toxic Cl. perfringens complex, their formation and interaction].
    Ispolatovskaia MV; Mikhaĭlovskaia LIa; Klimacheva LV; Blagoveshchenskiĭ VA; Larina IA
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Nov; 42(11):61-5. PubMed ID: 4290256
    [No Abstract]   [Full Text] [Related]  

  • 4. Properties of Clostridium perfringens (welchii) type-A alpha-toxin (phospholipase C) purified by electrofocusing.
    Smyth CJ; Arbuthnott JP
    J Med Microbiol; 1974 Feb; 7(1):41-66. PubMed ID: 4369079
    [No Abstract]   [Full Text] [Related]  

  • 5. [A study of the soluble antigens of strains of Cl. perfringens isolated from the feces of healthy persons].
    Goeva OE; Borovik EB; Sidorenko GI
    Zh Mikrobiol Epidemiol Immunobiol; 1968 May; 45(5):43-6. PubMed ID: 4308712
    [No Abstract]   [Full Text] [Related]  

  • 6. [The study of the formation of lecithinase by Clostridium perfringens type A].
    Shemanova GF; Shakhanina KL; Vlasova EV; Borisova OK; Bakirov RD
    Biokhimiia; 1968; 33(3):561-9. PubMed ID: 4300426
    [No Abstract]   [Full Text] [Related]  

  • 7. [Characteristics of the immunologic response of animals to Clostridium perfringens anatoxin].
    Petrov RV; Shemanova GF; Panteleev EI; Dmitrieva LN; Vlasova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1977 May; (5):71-4. PubMed ID: 197752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Some data in favor of the enzymatic nature of Cl. perfringens and oedematiens toxins].
    Zhak SP
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Nov; 42(11):65-9. PubMed ID: 4290470
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sensitizing properties of purified concentrated Cl. perfringens toxoids].
    Kalinichenko NF; Starobinets ZG; Podgornaia LG; Biriukova SV
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Oct; 48(10):113-5. PubMed ID: 4330843
    [No Abstract]   [Full Text] [Related]  

  • 10. Production of toxic enzymes of Clostridium perfringens BP6K on technologically important media including a medium with Tween 80.
    Lettl A
    J Hyg Epidemiol Microbiol Immunol; 1978; 22(2):243-8. PubMed ID: 217931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of the proteolytic complex of Clostridium perfringens type A].
    Novoselova GN; Efimova NP
    Prikl Biokhim Mikrobiol; 1976; 12(6):890-903. PubMed ID: 191802
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cultural properties of C1. perfringens resistant and sensitive to morphocycline].
    Miasnikova IG; Bel'kevich EA
    Antibiotiki; 1977 Nov; 22(11):1008-11. PubMed ID: 202190
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of the interrelationship between the content of immunizing units and the immunogenicity of C1. perfringens anatoxins].
    Nenashev VP; Akhundova KA
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Aug; (8):93-6. PubMed ID: 173119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha toxoid of Clostridium perfringens. II. Immunogenicity of the toxoid.
    Ito A
    Jpn J Med Sci Biol; 1970 Feb; 23(1):21-30. PubMed ID: 4317538
    [No Abstract]   [Full Text] [Related]  

  • 15. Study of the reciprocal relationship of the exoantigens of Clostridium perfringens type A in the culture medium and the bacterial cells during cultivation.
    Shemanova GF; Gorshkova VI; Borisova OK; Shakhanina KL
    Folia Microbiol (Praha); 1970; 15(1):23-33. PubMed ID: 4312434
    [No Abstract]   [Full Text] [Related]  

  • 16. Antitoxin response in cattle vaccinated with Clostridium perfringens type C toxoid.
    Kennedy KK; Norris SJ; Beckenhauer WH; White RG
    Vet Med Small Anim Clin; 1977 Jul; 72(7):1213-5. PubMed ID: 196381
    [No Abstract]   [Full Text] [Related]  

  • 17. The International Reference Preparations of Clostridium welchii (C. perfringens) beta and epsilon toxoids.
    Davidson I; Gray AK; Hebert CN; Lesslie IW
    Bull World Health Organ; 1978; 56(4):641-8. PubMed ID: 215337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The isolation and properties of Clostridium perfringens collagenase].
    Levdikova GA
    Biokhimiia; 1966; 31(4):821-30. PubMed ID: 4299366
    [No Abstract]   [Full Text] [Related]  

  • 19. [The toxins of Clostridium perfringens type C].
    Nedialkov S; Peichev B
    Vet Med Nauki; 1974; 11(2):73-8. PubMed ID: 4370604
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperimmunization of horses with alpha toxoid of Clostridium perfringens.
    Yanamoto A; Ito A; Murata R; Uematsu N; Nagai K
    Jpn J Med Sci Biol; 1970 Apr; 23(2):111-5. PubMed ID: 4318177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.